|
NUP85 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.289000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.471200E-01 |
| Normal-vs-Stage2 |
1.449810E-01 |
| Normal-vs-Stage3 |
3.313400E-01 |
| Normal-vs-Stage4 |
6.036400E-01 |
| Stage1-vs-Stage2 |
4.430100E-02 |
| Stage1-vs-Stage3 |
6.087800E-01 |
| Stage1-vs-Stage4 |
8.840400E-01 |
| Stage2-vs-Stage3 |
2.636500E-02 |
| Stage2-vs-Stage4 |
1.010040E-01 |
| Stage3-vs-Stage4 |
8.268400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.832990E-01 |
| Normal-vs-AfricanAmerican |
1.750160E-01 |
| Normal-vs-Asian |
2.788200E-01 |
| Caucasian-vs-AfricanAmerican |
6.662600E-01 |
| Caucasian-vs-Asian |
8.055200E-01 |
| AfricanAmerican-vs-Asian |
8.218200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.485600E-01 |
| Normal-vs-Female |
5.814800E-01 |
| Male-vs-Female |
7.569600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.537400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.556200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.761000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.276200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.173000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.500760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.893400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.641600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.924800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.838000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.344600E-01 |
| Classical-VS-Follicular |
5.1744000195697E-09 |
| Classical-VS-Other |
2.515600E-01 |
| Classical-VS-Normal |
2.161700E-02 |
| Tall-VS-Follicular |
1.7636000004817E-07 |
| Tall-VS-Other |
3.565200E-01 |
| Tall-VS-Normal |
3.028100E-02 |
| Follicular-VS-Other |
3.139800E-01 |
| Follicular-VS-Normal |
3.609400E-04 |
| Other-VS-Normal |
7.914400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.439400E-01 |
| Normal-vs-N1 |
6.341600E-01 |
| N0-vs-N1 |
4.513200E-01 |
|
|
